Drug Interactions Database

6278 interactions from BNF 85 - Check your medicines

Source: BNF 85
lamotrigine desmopressin

increases risk of hyponatraemia

Unknown Theoretical
lamotrigine etonogestrel

decreases effects

Unknown Theoretical
lamotrigine levonorgestrel

decreases effects

Unknown Theoretical
lamotrigine norethisterone

decreases effects

Unknown Theoretical
lanthanum antifungals,azoles

decreases absorption

Unknown Theoretical
lanthanum antimalarials

decreases absorption

Unknown Theoretical
lanthanum chloroquine

decreases absorption

Unknown Theoretical
lanthanum hydroxychloroquine

decreases absorption

Unknown Theoretical
lanthanum ketoconazole

decreases absorption

Unknown Theoretical
lanthanum quinolones

decreases exposure

Unknown Study
lanthanum thyroidhormones

decreases absorption

Unknown Study
lapatinib afatinib

increases exposure

Unknown Study
lapatinib aliskiren

increases exposure

Unknown Theoretical
lapatinib alpelisib

increases exposure

Unknown Theoretical
lapatinib antihistamines,non-sedating

increases exposure

Unknown Theoretical
lapatinib apixaban

increases exposure

Unknown Theoretical
lapatinib berotralstat

increases exposure

Unknown Study
lapatinib betablockers,non-selective

increases exposure

Unknown Study
lapatinib ceritinib

increases exposure

Unknown Theoretical
lapatinib colchicine

increases exposure

Unknown Theoretical
lapatinib coumarins

increases risk of bleedingevents

Unknown Theoretical
lapatinib dabigatran

increases exposure

Unknown Theoretical
lapatinib digoxin

increases exposure

Unknown Theoretical
lapatinib edoxaban

increases exposure

Unknown Theoretical
lapatinib erlotinib

increases exposure

Unknown Theoretical
lapatinib everolimus

increases exposure

Unknown Theoretical
lapatinib fexofenadine

increases exposure

Unknown Theoretical
lapatinib fidaxomicin

increases exposure

Unknown Study
lapatinib gilteritinib

increases exposure

Unknown Theoretical
lapatinib larotrectinib

increases exposure

Unknown Theoretical
lapatinib lomitapide

increases exposure

Unknown Theoretical
lapatinib loperamide

increases exposure

Unknown Theoretical
lapatinib nadolol

increases exposure

Unknown Study
lapatinib nintedanib

increases exposure

Unknown Study
lapatinib paclitaxel

increases exposure

Unknown Study
lapatinib phenindione

increases risk of bleedingevents

Unknown Theoretical
lapatinib pibrentasvir

increases exposure

Unknown Theoretical
lapatinib relugolix

increases exposure

Unknown Study
lapatinib rimegepant

increases exposure

Unknown Theoretical
lapatinib sirolimus

increases exposure

Unknown Theoretical
lapatinib talazoparib

increases exposure

Unknown Study
lapatinib taxanes

increases exposure

Unknown Study
lapatinib theactivecomponentofsacituzumabgovitecan

increases exposure

Unknown Theoretical
lapatinib thrombininhibitors

increases exposure

Unknown Theoretical
lapatinib tigecycline

increases exposure

Unknown Anecdotal
lapatinib topotecan

increases exposure

Unknown Study
lapatinib trametinib

increases concentration

Unknown Theoretical
lapatinib venetoclax

increases exposure

Unknown Theoretical
lapatinib vincaalkaloids

increases exposure

Unknown Theoretical
larotrectinib combinedhormonalcontraceptives

decreases efficacy

Unknown Theoretical
Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.